4.6 Article

Ubp-M serine 552 phosphorylation by cyclin-dependent kinase 1 regulates cell cycle progression

Journal

CELL CYCLE
Volume 12, Issue 19, Pages 3219-3227

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cc.26278

Keywords

Ubp-M; CDK1; phosphorylation; H2A deubiquitination; gene expression; cell cycle; G(2)/M phase; CRM1

Categories

Funding

  1. NIH [GM081489, P30 AR48311]

Ask authors/readers for more resources

In eukaryotic cells, genomic DNA is organized into a chromatin structure, which not only serves as the template for DNA-based nuclear processes, but also as a platform integrating intracellular and extracellular signals. Although much effort has been spent to characterize chromatin modifying/remodeling activities, little is known about cell signaling pathways targeting these chromatin modulators. Here, we report that cyclin-dependent kinase 1 (CDK1) phosphorylates the histone H2A deubiquitinase Ubp-M at serine 552 (S552P), and, importantly, this phosphorylation is required for cell cycle progression. Mass spectrometry analysis confirmed Ubp-M is phosphorylated at serine 552, and in vitro and in vivo assays demonstrated that CDK1/cyclin B kinase is responsible for Ubp-M S552P. Interestingly, Ubp-M S552P is not required for Ubp-M tetramer formation, deubiquitination activity, substrate specificity, or regulation of gene expression. However, Ubp-M S552P is required for cell proliferation and cell cycle G(2)/M phase progression. Ubp-M S552P reduces Ubp-M interaction with nuclear export protein CRM1 and facilitates Ubp-M nuclear localization. Therefore, these studies confirm that Ubp-M is phosphorylated at S552 and identify CDK1 as the enzyme responsible for the phosphorylation. Importantly, this study specifically links Ubp-M S552P to cell cycle G(2)/M phase progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biophysics

The N-terminal domain of the A12.2 subunit stimulates RNA polymerase I transcription elongation

Catherine E. Scull, Aaron L. Lucius, David A. Schneider

Summary: This study investigates the structural and functional differences among the three RNA polymerases in eukaryotes, as well as the specific functions and gene expression regulatory mechanisms of the A12 subunit of Pol I.

BIOPHYSICAL JOURNAL (2021)

Article Biochemistry & Molecular Biology

The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of RNA polymerase I in vivo and in vitro

Ruth Q. Jacobs, Abigail K. Huffines, Marikki Laiho, David A. Schneider

Summary: This study elucidates the mechanism of Pol I inhibition by BMH-21 and represents a critical step forward in the development of this compound and its derivatives for clinical use.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Correction Biochemistry & Molecular Biology

USP49-Mediated Histone H2B Deubiquitination Regulates HCT116 Cell Proliferation through MDM2-p53 Axis (vol 42, e00434-21, 2022)

Lei Shi, Xiangyu Shen, Hengbin Wang, Yuan Shen

MOLECULAR AND CELLULAR BIOLOGY (2022)

Article Biology

miR-486 is essential for muscle function and suppresses a dystrophic transcriptome

Adrienne Samani, Rylie M. Hightower, Andrea L. Reid, Katherine G. English, Michael A. Lopez, J. Scott Doyle, Michael J. Conklin, David A. Schneider, Marcas M. Bamman, Jeffrey J. Widrick, David K. Crossman, Min Xie, David Jee, Eric C. Lai, Matthew S. Alexander

Summary: miR-486 plays a significant role in muscle function, with reduced expression associated with Duchenne muscular dystrophy. It is essential for normal muscle function and contributes to pathological remodeling in dystrophin-deficient muscle. Additionally, it serves as a useful biomarker for disease progression. The use of multiple omic platforms is effective in identifying in vivo miR-486 target transcripts.

LIFE SCIENCE ALLIANCE (2022)

Article Multidisciplinary Sciences

PCGF6 controls neuroectoderm specification of human pluripotent stem cells by activating SOX2 expression

Xianchun Lan, Song Ding, Tianzhe Zhang, Ying Yi, Conghui Li, Wenwen Jin, Jian Chen, Kaiwei Liang, Hengbin Wang, Wei Jiang

Summary: This study reveals that PCGF6 plays a crucial role in determining the lineage specification of human pluripotent stem cells by promoting neuroectoderm differentiation and repressing mesendoderm differentiation. The activation of the SOX2 gene and the repression of the WNT/beta-catenin signaling pathway are key mechanisms involved in this process.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Critical role of lncEPAT in coupling dysregulated EGFR pathway and histone H2A deubiquitination during glioblastoma tumorigenesis

Linlin Li, Aidong Zhou, Yanjun Wei, Feng Liu, Peng Li, Runping Fang, Li Ma, Sicong Zhang, Longqiang Wang, Jinze Liu, Hope T. Richard, Yiwen Chen, Hengbin Wang, Suyun Huang

Summary: In this study, a previously unidentified oncogenic lncRNA called lncEPAT was discovered to mediate the integration of the dysregulated EGFR pathway with H2A deubiquitination in tumorigenesis. LncEPAT interacts with deubiquitinase USP16 and inhibits its recruitment to chromatin, thereby blocking USP16-mediated H2A deubiquitination and repressing target gene expression. Depletion of lncEPAT promotes USP16-induced cell cycle arrest and cellular senescence, and represses tumor formation in GBM cells.

SCIENCE ADVANCES (2022)

Article Biochemistry & Molecular Biology

Transient-State Kinetic Analysis of the RNA Polymerase II Nucleotide Incorporation Mechanism

Zachariah I. Carter, Ruth Q. Jacobs, David A. Schneider, Aaron L. Lucius

Summary: Eukaryotic RNA polymerase II (Pol II) is a crucial enzyme in eukaryotic biology. By using transient-state kinetic techniques, we investigated the single nucleotide addition process of Pol II on a millisecond time scale, aiming to understand its nucleotide incorporation mechanism.

BIOCHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Identification of an E3 ligase that targets the catalytic subunit of RNA Polymerase I upon transcription stress

Stephanie Pitts, Hester Liu, Adel Ibrahim, Amit Garg, Catarina Mendes Felgueira, Asma Begum, Wenjun Fan, Selina Teh, Jin-Yih Low, Brittany Ford, David A. Schneider, Ronald Hay, Marikki Laiho

Summary: The study reveals that F-box protein FBXL14 regulates the stability of the Pol I complex and promotes the degradation of specific subunits under transcription stress.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Rate of transcription elongation and sequence-specific pausing by RNA polymerase I directly influence rRNA processing

Abigail K. Huffines, Krysta L. Engel, Sarah L. French, Yinfeng Zhang, Olga V. Viktorovskaya, David A. Schneider

Summary: Transcription of ribosomal DNA by RNA polymerase I (Pol I) is one of the initial steps in ribosome biogenesis. In this study, a mutant form of Pol I, rpa190-F1205H, was used to investigate the link between transcription elongation and ribosome assembly. The mutant Pol I showed increased pause propensity during processive transcription elongation, both in vitro and in vivo. Additionally, alternative pause site preferences were observed in the mutant Pol I in vivo. These findings provide novel insights into Pol I elongation properties and its impact on rRNA processing and ribosome assembly.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Oncology

RNA Polymerase I Is Uniquely Vulnerable to the Small-Molecule Inhibitor BMH-21

Ruth Q. Jacobs, Kaila B. Fuller, Stephanie L. Cooper, Zachariah Carter, Marikki Laiho, Aaron L. Lucius, David A. Schneider

Summary: This study evaluates the specificity of the compound BMH-21 on transcription by Pols I, II, and III. The results show that Pol I is more sensitive to inhibition by BMH-21 compared to Pols II and III. These findings support the ongoing development of BMH-21 and its derivatives as potential therapeutic agents.

CANCERS (2022)

Article Multidisciplinary Sciences

Expression of RNA polymerase I catalytic core is influenced by RPA12

Brittany L. Ford, Ting Wei, Hester Liu, Catherine E. Scull, Saman M. Najmi, Stephanie Pitts, Wenjun Fan, David A. Schneider, Marikki Laiho

Summary: This study investigates the role of RPA12 in the regulation of RPA194 in human cancer cells. The results show that RPA12 affects the expression and localization of RPA194 and RPA135, but does not influence the transcription activity of Pol I or its engagement with chromatin. Additionally, RPA12 does not impact the degradation of RPA194 mediated by the small-molecule Pol I inhibitor BMH-21. These findings provide new insights into the regulatory factors controlling the expression of the Pol I catalytic subunit.

PLOS ONE (2023)

Review Cell Biology

The Pleiotropic Ubiquitin-Specific Peptidase 16 and Its Many Substrates

Jiahuan Zheng, Chunxu Chen, Chunqing Guo, Cody Caba, Yufeng Tong, Hengbin Wang

Summary: Ubiquitin-specific peptidase 16 (USP16) is a deubiquitinase involved in gene expression regulation, cell cycle progression, and various other functions. It was identified as a major deubiquitinase for histone H2A and has been found to deubiquitinate other proteins. USP16 is phosphorylated during mitosis and dephosphorylated during the metaphase/anaphase transition. It has been linked to DNA damage repair, immune disease, tumorigenesis, protein synthesis, coronary artery health, and male infertility, making it a potential therapeutic target for certain human diseases.

CELLS (2023)

Article Oncology

Small Molecule RBI2 Disrupts Ribosome Biogenesis through Pre-rRNA Depletion

Catherine E. Scull, Guy Twa, Yinfeng Zhang, Naiheng J. Yang, Robert N. Hunter III, Corinne E. Augelli-szafran, David A. Schneider

Summary: A newly identified ribosome biogenesis inhibitor, RBI2, has been shown to inhibit multiple types of cancer cells by inducing rapid polyadenylation and degradation of ribosomal RNA. This mechanism of action is distinct from previously described compounds and offers a potential novel pathway for cancer therapeutics targeting ribosome synthesis. This study reveals the importance of ribosome biogenesis in cancer cell growth and highlights the potential of RBI2 as a promising cancer therapeutic.

CANCERS (2023)

Article Cell Biology

Recognition of H2AK119ub plays an important role in RSF1-regulated early Xenopus development

Saeid Mohammad Parast, Deli Yu, Chunxu Chen, Amanda J. Dickinson, Chenbei Chang, Hengbin Wang

Summary: In this study, the researchers investigated the role of RSF1 in early embryonic development using Xenopus laevis as a model organism. They found that knockdown of RSF1 resulted in defects in gastrulation as well as neural and neural crest development. Furthermore, they demonstrated that the recognition of the H2AK119ub mark by RSF1 is important for its function during embryonic development.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Correction Biochemistry & Molecular Biology

Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment (vol 28, pg 1590, 2021)

Victoria Sanchez-Martin, David A. Schneider, Matilde Ortiz-Gonzalez, Ana Soriano-Lerma, Angel Linde-Rodriguez, Virginia Perez-Carrasco, Jose Gutierrez-Fernandez, Marta Cuadros, Juan C. Morales, Carlos Gonzalez, Miguel Soriano, Jose A. Garcia-Salcedo

CELL CHEMICAL BIOLOGY (2021)

No Data Available